Goldman Sachs Alternatives logo

Goldman Sachs Alternatives

Crunchbase
Crunchbase

Deals on record

6

Common Fundraising Type

Series B

NYSHEX logo
NYSHEX

Container shipping

Collate Capital logo
NewRoad Capital logo
Intercontinental Exchange logo
Goldman Sachs Alternatives logo
Blumberg Capital logo

The New York Shipping Exchange (NYSHEX) provides a technology platform to improve contract fulfillment and reduce economic waste in the container shipping industry.

Series C
Undisclosed
11/20/2024
Article
Simbe logo
Simbe

Retail technology

Goldman Sachs Alternatives logo
Valo Ventures logo
Eclipse logo

Simbe develops advanced autonomous robots and software solutions to enhance retail operations through item-scanning and data insights.

Series C
$50M
11/06/2024
Article
Seaport Therapeutics logo
Seaport Therapeutics

Neuropsychiatric

General Atlantic logo
T. Rowe Price Associates logo
Sofinnova Investments logo
Third Rock Ventures logo
PureTech Health logo
Invus logo
Goldman Sachs Alternatives logo
Foresite Capital logo

Seaport Therapeutics develops neuropsychiatric medicines using its Glyph technology platform to enhance oral bioavailability and reduce side effects, with a focus on treating depression, anxiety, and other disorders.

Series B
$225M
10/22/2024
Article
BrightNight logo
BrightNight

Renewable energy

Goldman Sachs Alternatives logo

BrightNight is a U.S. renewable power platform focused on delivering clean, dispatchable power solutions.

Hybrid
$840M
10/07/2024
Article

Triveni Bio is a biotech company developing novel antibody treatments for immunological and inflammatory disorders.

Series B
$115M
10/02/2024
Article
Vicebio logo
Vicebio

Biopharmaceutical

TCGX logo
venBio logo
UniQuest logo
Medicxi logo
Goldman Sachs Alternatives logo
Avoro Ventures logo

Vicebio Ltd is a biopharmaceutical company developing next-generation multivalent respiratory virus vaccines using proprietary Molecular Clamp technology.

Series B
$100M
09/23/2024
Article